This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis | MicrobiomeTrials
← Back to trials NCT07697456
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis Recruiting PHASE2 INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2026-07-31Est. Completion: 2031-10
Enrollment target: 2,000 participantsLocations Digestive Health Specialists /ID# 280827, Dothan, Alabama, United States Elite Clinical Studies /ID# 280477, Phoenix, Arizona, United States Clinnova Research /ID# 280509, Anaheim, California, United States Gastro Care Institute /ID# 281071, Lancaster, California, United States United Medical Doctors - Los Alamitos /ID# 281125, Los Alamitos, California, United States Inland Empire Liver Foundation - Rialto /ID# 280775, Rialto, California, United States Peak Gastroenterology Associates - Colorado Springs - North Cascade Avenue /ID# 280507, Colorado Springs, Colorado, United States Clinical Research of Osceola /ID# 280593, Kissimmee, Florida, United States Research Associates of South Florida /ID# 280929, Miami, Florida, United States Advanced Research Institute, Inc /ID# 281062, New Port Richey, Florida, United States Gastroenterology Associates of Central Georgia /ID# 280464, Macon, Georgia, United States Gastroenterology Consultants - Roswell /ID# 281235, Roswell, Georgia, United States Treasure Valley Medical Research /ID# 281778, Boise, Idaho, United States Southwest Gastroenterology - Oak Lawn /ID# 280841, Oak Lawn, Illinois, United States Other microbiome trials you might be interested in Inflammatory Bowel Disease Crohn's Disease Ulcerative Colitis
Background:
Inflammatory bowel disease (IBD) is a term used to describe disorders that cause long-term inflammation in …
Bethesda, United States Est. completion Jun 1, 2036
Inflammatory Bowel Disease (IBD)
This observational study will use intestinal ultrasound images to help develop computer programs that may make it easier…
Vancouver, Canada Est. completion Feb 1, 2027
Gastroenterology Health Partners /ID# 284144, Louisville, Kentucky, United States
Vector Clinical Trials /ID# 280843, Las Vegas, Nevada, United States
New York Gastroenterology Associates - Upper East Side /ID# 281767, New York, New York, United States
University Gastroenterology - Providence - Staniford Street /ID# 280919, Providence, Rhode Island, United States
Gastro One - Memphis /ID# 283948, Memphis, Tennessee, United States
Novel Research - Bellaire /ID# 280925, Bellaire, Texas, United States
Amel Med /ID# 283864, Georgetown, Texas, United States
Integrity Advanced Therapeutics /ID# 283871, Houston, Texas, United States
Southern Star Research Institute /ID# 280822, San Antonio, Texas, United States
Washington Gastroenterology - Tacoma /ID# 284143, Tacoma, Washington, United States
The Vancouver Clinic /ID# 280497, Vancouver, Washington, United States
China Medical University Hospital /ID# 280630, Taichung, Taiwan Phase 4
Recruiting
Children Aged 6 Years and Above With Moderate - to - Severe Active Crohn's Disease
This study is a real - world clinical research of adalimumab. The project plans to enroll 30 subjects, aiming to evaluat…
Guangzhou, China Est. completion Mar 2029